• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉溶栓的实践模式与障碍:沙特阿拉伯神经科医生的一项调查

Practice Patterns and Barriers for Intravenous Thrombolysis: A Survey of Neurologists in Saudi Arabia.

作者信息

Alanazy Mohammed H, Barakeh Rima B, Asiri Alanood, Edrees Maha F, Abuzinadah Ahmad R, Aljafen Bandar N, Muayqil Taim

机构信息

Department of Internal Medicine, King Saud University Medical City and College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

出版信息

Neurol Res Int. 2018 Feb 13;2018:1695014. doi: 10.1155/2018/1695014. eCollection 2018.

DOI:10.1155/2018/1695014
PMID:29666704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5831958/
Abstract

Only a small fraction of patients with acute ischemic stroke receive intravenous thrombolysis (IVT). We sought to assess barriers and practice patterns in using IVT for acute ischemic stroke among neurologists in Saudi Arabia. An electronic survey was sent to all neurologists registered with the Saudi Commission for Health Specialties. A total of 148 (77.5%) neurologists responded. The most common reported barriers for IVT administration were delayed presentation to hospitals (82.4%) and unclear time of symptom onset (50.0%). Only 9.9% of neurologists reported strict adherence to the American Heart Association/American Stroke Association guidelines for IVT administration. The most frequently waived criteria were "minor stroke with National Institutes of Health Stroke Scale [NIHSS] < 5" (49.4%) and "seizure at onset" (45.7%). For the extended 3-4.5-hour window, 18.5% of neurologists reported strict adherence to the four exclusion criteria. The most frequently waived criteria were "age older than 80 years" (53.1%) and "history of both diabetes and prior stroke" (42.0%). In conclusion, most neurologists do not adhere to the IVT exclusion criteria. However, little consensus exists regarding which criteria do not interfere with IVT administration. Barriers to IVT administration were identified and require immediate action by healthcare authorities in Saudi Arabia.

摘要

仅有一小部分急性缺血性中风患者接受静脉溶栓治疗(IVT)。我们试图评估沙特阿拉伯神经科医生在使用IVT治疗急性缺血性中风方面的障碍和实践模式。向沙特卫生专业委员会注册的所有神经科医生发送了电子调查问卷。共有148名(77.5%)神经科医生回复。报告的IVT给药最常见障碍是到医院就诊延迟(82.4%)和症状发作时间不明(50.0%)。只有9.9%的神经科医生报告严格遵循美国心脏协会/美国中风协会的IVT给药指南。最常被放宽的标准是“美国国立卫生研究院卒中量表[NIHSS]<5的轻度中风”(49.4%)和“发病时癫痫发作”(45.7%)。对于延长至3 - 4.5小时的时间窗,18.5%的神经科医生报告严格遵循四项排除标准。最常被放宽的标准是“年龄大于80岁”(53.1%)和“糖尿病和既往中风史”(42.0%)。总之,大多数神经科医生不遵循IVT排除标准。然而,对于哪些标准不影响IVT给药几乎没有共识。确定了IVT给药的障碍,沙特阿拉伯的卫生当局需要立即采取行动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/5831958/c040d9e0aacd/NRI2018-1695014.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/5831958/c040d9e0aacd/NRI2018-1695014.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5e3/5831958/c040d9e0aacd/NRI2018-1695014.001.jpg

相似文献

1
Practice Patterns and Barriers for Intravenous Thrombolysis: A Survey of Neurologists in Saudi Arabia.静脉溶栓的实践模式与障碍:沙特阿拉伯神经科医生的一项调查
Neurol Res Int. 2018 Feb 13;2018:1695014. doi: 10.1155/2018/1695014. eCollection 2018.
2
Intravenous thrombolysis for ischemic stroke in the Veneto region: the gap between eligibility and reality.威尼托地区缺血性脑卒中的静脉溶栓治疗:适宜性与现实之间的差距。
J Thromb Thrombolysis. 2019 Jan;47(1):113-120. doi: 10.1007/s11239-018-1753-8.
3
Reasons for Exclusion From Intravenous Thrombolysis in Acute Ischemic Stroke: Experience From a Moroccan Stroke Unit.急性缺血性卒中患者被排除接受静脉溶栓治疗的原因:来自摩洛哥一家卒中单元的经验
Cureus. 2023 Jan 2;15(1):e33248. doi: 10.7759/cureus.33248. eCollection 2023 Jan.
4
Thrombolysis in acute ischemic stroke: Experience from a tertiary care centre in India.急性缺血性卒中的溶栓治疗:来自印度一家三级医疗中心的经验。
J Neurosci Rural Pract. 2014 Jan;5(1):25-30. doi: 10.4103/0976-3147.127867.
5
Determinants and Trends of the Use of Intravenous Thrombolysis for Minor Stroke: A Population-Based Study, 2016 to 2020.《2016 至 2020 年小卒中患者静脉溶栓应用的决定因素和趋势:一项基于人群的研究》。
Stroke. 2022 Nov;53(11):3289-3294. doi: 10.1161/STROKEAHA.122.038996. Epub 2022 Aug 10.
6
Intravenous thrombolysis for acute ischemic stroke in Greece: the Safe Implementation of Thrombolysis in Stroke registry 15-year experience.希腊急性缺血性卒中的静脉溶栓治疗:卒中溶栓安全实施注册研究的15年经验
Ther Adv Neurol Disord. 2018 Jun 28;11:1756286418783578. doi: 10.1177/1756286418783578. eCollection 2018.
7
Intravenous Thrombolysis or Medical Management for Minor Strokes.静脉溶栓或药物治疗轻微中风。
Thromb Haemost. 2023 Jul;123(7):734-743. doi: 10.1055/s-0043-1768150. Epub 2023 Apr 10.
8
Safety of Mechanical Thrombectomy with Combined Intravenous Thrombolysis in Stroke Treatment 4.5 to 9 Hours from Symptom Onset.机械取栓联合静脉溶栓治疗发病 4.5-9 小时内脑卒中的安全性。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105204. doi: 10.1016/j.jstrokecerebrovasdis.2020.105204. Epub 2020 Aug 13.
9
Eligibility for intravenous thrombolysis in acute ischemic stroke patients presenting in the 4.5-9 h window.急性缺血性脑卒中患者在 4.5-9 小时窗口期内进行静脉溶栓治疗的适应证。
Neuroradiology. 2020 Jun;62(6):733-739. doi: 10.1007/s00234-020-02375-2. Epub 2020 Feb 1.
10
Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.慢性颅内出血静脉溶栓的安全性:一项为期五年的多中心研究。
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):620-624. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.037.

引用本文的文献

1
Exploring the needs of stroke patients after discharge from rehabilitation centres in Saudi Arabian communities: An IPA qualitative exploratory study design.探索沙特阿拉伯社区康复中心出院后中风患者的需求:IPA 定性探索性研究设计。
PLoS One. 2023 Sep 8;18(9):e0291263. doi: 10.1371/journal.pone.0291263. eCollection 2023.
2
Patterns and outcomes of stroke thrombolysis in a large tertiary care hospital in Riyadh, Saudi Arabia.沙特阿拉伯利雅得一家大型三级护理医院的卒中溶栓的模式和结果。
Neurosciences (Riyadh). 2021 Apr;26(2):199-206. doi: 10.17712/nsj.2021.2.20200171.
3
Secondary stroke prevention among stroke survivors in Riyadh city, Saudi Arabia. Risk Knowledge, adherence to stroke discharge medications and preventive strategies.

本文引用的文献

1
The incidence of pregnancy-related stroke: A systematic review and meta-analysis.妊娠相关中风的发病率:一项系统评价和荟萃分析。
Int J Stroke. 2017 Oct;12(7):687-697. doi: 10.1177/1747493017723271.
2
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.
3
Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
沙特阿拉伯利雅得市脑卒中幸存者的二级预防。风险知识、对脑卒中出院药物治疗的依从性和预防策略。
Neurosciences (Riyadh). 2020 Apr;25(2):118-128. doi: 10.17712/nsj.2020.2.20190059.
4
Saudi neurology residents' knowledge and attitudes toward intravenous thrombolysis in patients with acute ischemic stroke.沙特神经病学住院医师对急性缺血性脑卒中患者静脉溶栓治疗的知识与态度。
J Family Med Prim Care. 2020 Jan 28;9(1):192-196. doi: 10.4103/jfmpc.jfmpc_924_19. eCollection 2020 Jan.
5
A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change.在沙特阿拉伯发展缺血性脑卒中治疗的国家经济和临床模式:呼吁变革。
Int J Stroke. 2019 Oct;14(8):835-842. doi: 10.1177/1747493019851284. Epub 2019 May 23.
远程医疗在心血管和卒中护理中的应用建议:美国心脏协会的政策声明。
Circulation. 2017 Feb 14;135(7):e24-e44. doi: 10.1161/CIR.0000000000000475. Epub 2016 Dec 20.
4
Neuroendocrinal, Neurodevelopmental, and Embryotoxic Effects of Recombinant Tissue Plasminogen Activator Treatment for Pregnant Women with Acute Ischemic Stroke.重组组织型纤溶酶原激活剂治疗急性缺血性卒中孕妇的神经内分泌、神经发育及胚胎毒性作用
Front Neurosci. 2016 Feb 25;10:51. doi: 10.3389/fnins.2016.00051. eCollection 2016.
5
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.血管内血栓切除术治疗大动脉闭塞性缺血性卒中的Meta 分析:来自五项随机试验的个体患者数据汇总分析
Lancet. 2016 Apr 23;387(10029):1723-31. doi: 10.1016/S0140-6736(16)00163-X. Epub 2016 Feb 18.
6
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.静脉注射阿替普酶用于急性缺血性脑卒中的纳入和排除标准的科学依据:美国心脏协会/美国卒中协会医疗保健专业人员的声明。
Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22.
7
2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.2015年美国心脏协会/美国卒中协会对2013年急性缺血性卒中患者早期管理指南中血管内治疗部分的重点更新:美国心脏协会/美国卒中协会给医疗专业人员的指南
Stroke. 2015 Oct;46(10):3020-35. doi: 10.1161/STR.0000000000000074. Epub 2015 Jun 29.
8
Intravenous fibrinolysis eligibility: a survey of stroke clinicians' practice patterns and review of the literature.静脉溶栓的适应证:对卒中临床医生实践模式的调查及文献综述
J Stroke Cerebrovasc Dis. 2014 Sep;23(8):2130-2138. doi: 10.1016/j.jstrokecerebrovasdis.2014.03.024. Epub 2014 Aug 10.
9
Adherence to Third European Cooperative Acute Stroke Study 3- to 4.5-hour exclusions and association with outcome: data from Get with the Guidelines-Stroke.遵循欧洲急性卒中协作研究第三次研究中3至4.5小时的排除标准及其与预后的关联:来自“遵循指南-卒中”项目的数据
Stroke. 2014 Sep;45(9):2745-9. doi: 10.1161/STROKEAHA.114.005443. Epub 2014 Aug 7.
10
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.1990-2010 年全球及各区域卒中负担变化:来自 2010 年全球疾病负担研究的结果。
Lancet. 2014 Jan 18;383(9913):245-54. doi: 10.1016/s0140-6736(13)61953-4.